India, the pharmacy of the world, must protect its generic medicine industry

The country’s wavering stance on data exclusivity, which will allow corporations to hold a monopoly on drugs, risks global ...
JD Supra

EU Pharma Law Package: Council Position on Reduction of Regulatory Exclusivity Rights

On 4 June 2025, the Council of the EU adopted its position on the EU Pharma Law Package legislative proposal to revise the EU’s general pharmaceutical legislation. The Council, consisting of all the ...
Nasdaq

Windtree Therapeutics Announces Strategic Pathway for 7.5 Years of U.S. Exclusivity for Istaroxime in Cardiogenic Shock

Windtree Therapeutics, Inc. announced that it has received guidance from intellectual property and FDA experts regarding a potential strategy for its drug istaroxime, which targets cardiogenic shock.
JD Supra

China Formalizes Regulatory Data Protection Mechanism

Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data Protection (hereinafter referred to as the 'Draft for Comments'), ...